文献速递产科麻醉

去氧肾上腺素间断推注与持续输注对剖宫产母婴结局比较:系统评价与荟萃分析

Comparison of Phenylephrine Bolus and Infusion Regimens on Maternal and Fetal Outcomes During Cesarean Delivery: A Systematic Review and Meta-Analysis.
PubMed 文献 · Anesth Analg · 2024-11-15

该系统评价与荟萃分析纳入15项研究共2153例椎管内麻醉剖宫产产妇,比较去氧肾上腺素间断推注与预防性持续输注对母婴结局的影响。结果显示推注组产前低血压发生率显著增高(RR 2.34,95%CI 1.72-3.18),但反应性高血压和心动过缓较少,呕吐较多;胎儿结局无显著差异。

要点

  • 去氧肾上腺素持续输注较间断推注显著降低剖宫产产前低血压发生率。
  • 推注组反应性高血压和心动过缓发生率较低,但呕吐发生率较高。
  • 两组胎儿脐动脉pH、脐静脉pH、酸中毒及Apgar评分无显著差异。

核心结论

  • 预防性去氧肾上腺素持续输注较治疗性或预防性间断推注显著降低椎管内麻醉剖宫产产妇产前低血压发生率。
  • 对于无既存高血压疾病或心血管疾病的产妇,可考虑预防性持续输注以降低产前低血压风险。

研究设计与样本

  • 系统评价与荟萃分析,检索Medline、Embase、Cochrane及US Clinical registry数据库。
  • 纳入15项研究,共2153例在脊髓或腰硬联合麻醉下接受剖宫产的产妇。
  • 比较去氧肾上腺素间断推注(治疗性或预防性)与持续输注(固定或可变速率)对母婴结局的影响,采用随机效应模型进行定量分析,偏倚风险采用Cochrane R0B 2.0工具评估。

主要发现

  • 推注组产前低血压发生率显著高于输注组(RR 2.34,95%CI 1.72-3.18)。
  • 推注组反应性高血压(RR 0.48,95%CI 0.29-0.79)和心动过缓(RR 0.57,95%CI 0.41-0.79)发生率显著低于输注组。
  • 推注组呕吐发生率显著高于输注组(RR 2.15,95%CI 1.53-3.03)。
  • 恶心发生率及任何胎儿结局(脐动脉pH、paO2、脐静脉pH、胎儿酸中毒、1分钟和5分钟Apgar评分)在两组间无统计学显著差异。
  • 3项研究存在高偏倚风险。

临床怎么用

  • 在无既存高血压疾病或心血管疾病的剖宫产产妇中,可考虑预防性去氧肾上腺素持续输注以减少产前低血压。
  • 对于高血压或心血管疾病患者,最佳血流动力学管理仍需更多证据指导。

局限性

  • 3项纳入研究存在高偏倚风险。
  • 对于高血压或心血管疾病患者的证据不足,需更多研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A systematic review and meta-analysis was conducted to compare phenylephrine boluses versus prophylactic infusion in parturients undergoing cesarean delivery under spinal or combined spinal-epidural anesthesia on feto-maternal outcomes. METHODS: Medline, Embase, Cochrane, and US Clinical registry databases were searched. Studies comparing phenylephrine boluses (both therapeutic and prophylactic) with infusion (both fixed- and variable-rate) assessing various feto-maternal outcomes were included. The primary outcome was the incidence of maternal hypotension. Secondary maternal outcomes included the incidence of reactive hypertension, bradycardia, nausea, or vomiting; secondary neonatal outcomes included umbilical arterial pH, partial pressure of oxygen (paO2), umbilical venous pH, fetal acidosis, Apgar Scores at 1 and 5 minutes. All outcomes were quantitatively analyzed using the random effects model. Risk of bias was assessed using the Cochrane Collaboration R0B 2.0 tool. RESULTS: We included 15 studies with 2153 parturients. The parturients receiving phenylephrine bolus during cesarean delivery under spinal or combined spinal-epidural anesthesia had a significant increase in the incidence of predelivery hypotension compared to phenylephrine infusion (risk ratio [RR], 2.34, 95% confidence interval [CI], 1.72-3.18). Reactive hypertension (RR, 0.48, 95% CI, 0.29-0.79) and bradycardia (RR, 0.57, 95% CI, 0.41-0.79) were less common in the parturients receiving phenylephrine bolus; whereas, vomiting (RR, 2.15, 95% CI, 1.53-3.03) was more common compared to the infusion group. No statistically significant difference was observed in the incidence of nausea or any fetal outcomes (umbilical artery pH, paO2, umbilical venous pH, fetal acidosis, and Apgar scores at 1 and 5 minutes) between either of the groups. Three studies had a high risk of bias. CONCLUSIONS: A prophylactic phenylephrine infusion significantly reduces the incidence of predelivery hypotension in parturients undergoing cesarean delivery under neuraxial anesthesia in comparison to the therapeutic or prophylactic phenylephrine bolus group. A prophylactic phenylephrine infusion may be considered in all parturients without preexisting hypertensive disorder or cardiovascular disorders to reduce the risk of predelivery hypotension. More evidence is needed to guide optimal hemodynamic management for patients with hypertensive or cardiovascular disorders.

来源:Anesth Analg,查看原文。版权归原作者所有。

引用

  1. Garg H, Narayanan M R V, Khanna P, et al. Comparison of Phenylephrine Bolus and Infusion Regimens on Maternal and Fetal Outcomes During Cesarean Delivery: A Systematic Review and Meta-Analysis. Anesth Analg. 2024. PMID: 39715512. doi:10.1213/ANE.0000000000007156

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。